# Lyell Immunopharma, Inc.: Form 8-K, filed Jun 26, 2025

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: 8-K
- Filed: 2025-06-26
- Accepted by EDGAR: Jun 26, 2025, 16:07 ET
- Period: 2025-06-20
- Accession: 0001193125-25-148897
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000119312525148897/d917552d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000119312525148897/

## Items reported

- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000119312525148897/d917552d8k.htm

Filed Jun 26, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-148897. Last ingested by Listed: Nov 14, 2026, 18:55 ET. No prices; not investment advice.
